Delivery Order SPE2DB20D3505-SPE2DB22FT5A9
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Advair HFA 230-21 MCG Inhaler 12GM. The $1,853.56 delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 MCG inhalers. The $2,523.96 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,747.87 firm-fixed-price delivery order is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The $2,056.62 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 mcg inhalers. The $12,265.08 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
- This federal contract award, valued at $2,801.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of an Advair HFA 115-21 MCG Inhaler, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG inhalers. The $1,688.82 firm-fixed-price contract has an ultimate completion date of August 17, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,870.49 Firm Fixed Price delivery order contract is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,720.28, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, valued at up to $999,999,999, which runs through November 2026. This IDC...
- This federal contract award, valued at $86,769.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a specialty medication, to support military and federal healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT5A9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 230-21 MCG Inhaler 12GM. The $1,247.49 delivery order falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award did not have a set-aside designation, indicating open competition. As a key supplier to the Department of Defense and Department of Veterans Affairs, Amerisourcebergen plays a critical role in ensuring the availability of essential medications and medical supplies for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/1/22 |